Volpara further expands its footprint in the lung cancer screening market with a strategic partnership with Seattle-based lung AI company Precision Medical Ventures (PMV), trading as RevealDx
News
Precision Medical Ventures announces the rebranding of Mindshare Medical to RevealDx and the appointment of Chris Wood as CEO.
Precision Medical Ventures announces the acquisition of Mindshare Medical to accelerate commercialization of RevealAI-Lung, a CADx software application with EU and Canadian regulatory approval.